Ignite Creation Date:
2024-07-17 @ 10:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06461312
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-06-06
Brief Title:
Combined PRF of the Pudendal Nerve With Ganglion Impar Block Effectively Alleviates Pudendal Neuralgia
Sponsor:
Peking University Peoples Hospital
Organization:
Peking University Peoples Hospital
Study Overview
Official Title:
Combined Pulsed Radiofrequency of the Pudendal Nerve With Ganglion Impar Block Effectively Alleviates Pudendal Neuralgia
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRF
Brief Summary:
Patients with pudendal neuralgia suffer from long-term pain which severely affects their quality of life Due to unclear etiology there is a lack of specific treatment methods The aim of this study is to evaluate the efficacy of combined pulsed radiofrequency with ganglion impar block therapy helps evaluate the effectiveness of this treatment method for pudendal neuralgia comparing it with traditional treatments or single interventions and providing guidance for clinical practice
Detailed Description:
We plan to enroll patients with pudendal neuralgia Pre-treatment we collected data including pain assessment anxiety depression catastrophizing and pain sensitivity scales Treatment involved ultrasound-guided pudendal nerve pulsed radiofrequency and X-ray-guided ganglion impar block The Patient Global Impression of Change PGIC and Numeric Rating Scale NRS were used as the main observation indicators to evaluate the treatment effect at 1 2 3 and 6 months postoperatively followed by correlation analysis with the scores of relevant scales
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None